Kunming Biomed International (KBI) has developed and characterized a large scale of high fat diet (HFD)-induced NHP models of metabolic diseases and liver diseases including steatosis, NASH and fibrosis. More than 1500 male cynomolgus monkeys have been fed with HFD over a period of 1-6 years and majority of them have developed obesity and diabetic phenotypes as well as progressed to metabolic complications including CKD, CVD and metabolic liver diseases. MRI-based liver fat quantification and percutaneous liver biopsy have exposed significant numbers of monkeys that manifested the full spectrum of non-alcoholic fatty liver disease (NAFLD) ranging from steatosis (more than 800 monkeys) to NASH (more than 800 monkeys) and fibrosis (more than 800 monkeys).
 
KBI will present this work in this year’s The Liver Meeting® 2017 of American Association for the Study of Liver Diseases (AASLD), hold in Washington D.C., USA, October 20 -24, 2017. KBI’s meeting abstract “Development and Characterization of High Fat Diet-induced Non-human Primate Models of Liver Diseases: Steatosis, NASH and Fibrosis” has been honorably appointed as a Presidential Poster of Distinction for presentation at the meeting, ranking to the top 10% of scored poster abstracts by the Scientific Program Committee of AASLD. KBI’s poster will receive special recognition in the poster hall during the presentation day. Welcome to visit our poster during the meeting or search our abstract from the journal of HEPATOLOGY in its October supplement. Our poster presentation details are below:
    Publication Number: 1959
    Session Date and Time: October 23, 2017 from 8:00am to 5:30pm
    Session: Steatohepatitis: Experimental
    Location: Hall D, Walter E. Washington Convention Center, Washington D.C. USA

Also, KBI’s poster is also accessible from AASLD meeting’s ePoster. The poster QR is: